cnbc.com / .cnbc-com-health-care / Page 2

Novo Nordisk's Martin Holst Lange preveiwed the company's obesity pill, while OpenAI launches new initiative to speed up scientific discovery.

The move would make Florida the first U.S. state to withdraw from mandates credited with boosting vaccination rates and preventing infectious disease outbreaks.

It is the latest U.S. investment by a drugmaker as President Donald Trump threatens to impose tariffs on pharmaceuticals imported into the U.S.

Health and Human Services Secretary Robert F. Kennedy Jr. has taken measures to overhaul federal health agencies and change U.S. immunization policies.

The internal announcement comes at a tumultuous time for the CDC and its workforce, which is still reeling from the shooting on Aug. 8.

The White House on Thursday said President Donald Trump had fired CDC Director Susan Monarez after she refused to resign.

Susan Monarez, a longtime federal government scientist, was sworn in on July 31.

It's unclear how easily patients without high risk factors will be able to get a shot, and whether insurance plans will still cover the shots for healthy Americans.

Eli Lilly's Daniel Skovronsky talks the latest orforglipron trial, while UnitedHealth Group CEO Stephen Hemsley is moving quickly on a strategic turnaround.

Eli Lilly now has the clinical trial data required to start filing for approvals of the drug for chronic weight management with global regulators.